Northwest Biotherapeutics Bags Exclusive In-License of Dendritic Cell Technology
Northwest Biotherapeutics has announced an exclusive license from Roswell Park Comprehensive Cancer Center for a portfolio of dendritic cell technologies and intellectual property (IP).
Dendritic Cell Technologies | 18/06/2024 | By Aishwarya | 284
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy